Cargando…
COVISHIELD (AZD1222) VaccINe effectiveness among healthcare and frontline Workers of INdian Armed Forces: Interim results of VIN-WIN cohort study
BACKGROUND: On 16 Jan 2021, India launched its immunization program against COVID-19. Among the first recipients were 1.59 million Health Care Workers (HCWs) and Frontline Workers (FLWs) of the Indian Armed Forces, who were administered COVISHIELD (Astra Zeneca). We present an interim analysis of va...
Autores principales: | Ghosh, Subhadeep, Shankar, Subramanian, Chatterjee, Kaustuv, Chatterjee, Kaushik, Yadav, Arun Kumar, Pandya, Kapil, Suryam, Vani, Agrawal, Sunil, Ray, Sougat, Phutane, Vivek, Datta, Rajat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313084/ https://www.ncbi.nlm.nih.gov/pubmed/34334892 http://dx.doi.org/10.1016/j.mjafi.2021.06.032 |
Ejemplares similares
-
AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal
por: Sah, Ranjit, et al.
Publicado: (2021) -
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
por: Jeewandara, Chandima, et al.
Publicado: (2021) -
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021) -
Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in Nepal
por: Poudel, Kapil Madi, et al.
Publicado: (2022) -
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2022)